HealthTechFundingNews5 days ago
ARK Invest joins Cellares' $277M round for cell therapy manufacturing
4 min read
Cathie Wood's ARK Invest invested $20 million in Cellares' Series D, bringing the total round to $277 million. Cellares, founded in 2019, aims to industrialize cell therapy manufacturing with its Cell Shuttle and Cell Q platforms to scale production and reduce costs for patient access.
Level
Hype check
Tap to vote and see what everyone thinks.
